Ibrahim M. Labouta

465 total citations
29 papers, 383 citations indexed

About

Ibrahim M. Labouta is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Ibrahim M. Labouta has authored 29 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 9 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Ibrahim M. Labouta's work include Synthesis and Characterization of Heterocyclic Compounds (14 papers), Synthesis and biological activity (14 papers) and Synthesis and Biological Evaluation (8 papers). Ibrahim M. Labouta is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (14 papers), Synthesis and biological activity (14 papers) and Synthesis and Biological Evaluation (8 papers). Ibrahim M. Labouta collaborates with scholars based in Egypt, India and France. Ibrahim M. Labouta's co-authors include Hayam M. A. Ashour, M. A. KHALIL, Rasha A. Nassra, Ahmed M. Hassan, Khadiga Ahmed Ismail, Manal N. Saudi, Povl Krogsgaard‐Larsen, Poul Jacobsen, Omaima M. Aboulwafa and Abdel-Khalek Mm and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical Sciences and European Journal of Medicinal Chemistry.

In The Last Decade

Ibrahim M. Labouta

28 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ibrahim M. Labouta Egypt 14 304 128 35 28 25 29 383
Sven Taylor Switzerland 11 271 0.9× 148 1.2× 52 1.5× 23 0.8× 49 2.0× 15 410
Francesco Piscitelli Italy 9 397 1.3× 94 0.7× 30 0.9× 34 1.2× 20 0.8× 12 505
V. I. Nikulin United States 10 205 0.7× 143 1.1× 28 0.8× 52 1.9× 14 0.6× 26 358
Dulce Garrido United States 11 183 0.6× 222 1.7× 48 1.4× 18 0.6× 21 0.8× 18 427
Peter H. Crackett United Kingdom 9 183 0.6× 91 0.7× 21 0.6× 21 0.8× 40 1.6× 18 295
Laura C. Meurer United States 11 175 0.6× 144 1.1× 15 0.4× 39 1.4× 27 1.1× 15 334
Varughese Alexander South Korea 10 211 0.7× 147 1.1× 10 0.3× 29 1.0× 17 0.7× 15 348
Reinhard Troschütz Germany 12 499 1.6× 141 1.1× 16 0.5× 37 1.3× 10 0.4× 64 545
R. G. Paronikyan Armenia 11 278 0.9× 86 0.7× 20 0.6× 31 1.1× 10 0.4× 71 346
Lisa R. Thompson United Kingdom 7 103 0.3× 155 1.2× 59 1.7× 19 0.7× 20 0.8× 8 289

Countries citing papers authored by Ibrahim M. Labouta

Since Specialization
Citations

This map shows the geographic impact of Ibrahim M. Labouta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim M. Labouta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim M. Labouta more than expected).

Fields of papers citing papers by Ibrahim M. Labouta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim M. Labouta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim M. Labouta. The network helps show where Ibrahim M. Labouta may publish in the future.

Co-authorship network of co-authors of Ibrahim M. Labouta

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim M. Labouta. A scholar is included among the top collaborators of Ibrahim M. Labouta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim M. Labouta. Ibrahim M. Labouta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mahran, Mona A., et al.. (2022). New tetrahydropyrimidine-1,2,3-triazole clubbed compounds: Antitubercular activity and Thymidine Monophosphate Kinase (TMPKmt) inhibition. Bioorganic Chemistry. 131. 106312–106312. 15 indexed citations
5.
Rizk, Ola H., et al.. (2018). Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents. Bioorganic Chemistry. 80. 721–732. 13 indexed citations
6.
Ashour, Hayam M. A., et al.. (2018). Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents. Bioorganic Chemistry. 80. 164–173. 28 indexed citations
7.
Ashour, Hayam M. A., et al.. (2018). Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Bioorganic Chemistry. 78. 358–371. 44 indexed citations
8.
Ashour, Hayam M. A., et al.. (2017). Target identification, lead optimization and antitumor evaluation of some new 1,2,4-triazines as c-Met kinase inhibitors. Bioorganic Chemistry. 73. 154–169. 25 indexed citations
9.
Ashour, Hayam M. A., et al.. (2017). Design, synthesis and molecular modeling studies of new series of antitumor 1,2,4-triazines with potential c-Met kinase inhibitory activity. Bioorganic Chemistry. 76. 154–165. 23 indexed citations
11.
Labouta, Ibrahim M., et al.. (1989). Synthesis of some substituted benzimidazoles with potential antimicrobial activity. Monatshefte für Chemie - Chemical Monthly. 120(6-7). 571–574. 19 indexed citations
12.
Labouta, Ibrahim M., et al.. (1988). Synthesis of some substituted triazolo[4,3-b][1,2,4]triazines as potential anticancer agents. Monatshefte für Chemie - Chemical Monthly. 119(5). 591–596. 8 indexed citations
13.
Labouta, Ibrahim M., E. FALCH, Hans Hjeds, et al.. (1987). Synthesis and biological activity of a GABAA agonist which has no effect on benzodiazepine binding and of structurally related glycine antagonists.. PubMed. 1(4). 261–74. 14 indexed citations
15.
OMAR, A.‐M. M. E., et al.. (1983). Arylidenepyruvic Acid Thiosemicarbazone and Thiazoline Derivatives As Potential Antimicrobial Agents. Journal of Pharmaceutical Sciences. 72(10). 1226–1228. 9 indexed citations
16.
Labouta, Ibrahim M., et al.. (1983). ChemInform Abstract: HYDROXY‐ AND AMINO‐SUBSTITUTED PIPERIDINECARBOXYLIC ACIDS AS Γ‐AMINOBUTYRIC ACID AGONISTS AND UPTAKE INHIBITORS. Chemischer Informationsdienst. 14(10). 1 indexed citations
17.
Jacobsen, Poul, Ibrahim M. Labouta, Kjeld Schaumburg, Erik Falch, & Povl Krogsgaard‐Larsen. (1982). Hydroxy- and amino-substituted piperidinecarboxylic acids as .gamma.-aminobutyric acid agonists and uptake inhibitors. Journal of Medicinal Chemistry. 25(10). 1157–1162. 18 indexed citations
18.
SOLIMAN, F. S. G., et al.. (1979). 強力な抗新生物薬 II 新規チアゾロ〔1,2,4〕トリアジン誘導体. Pharmazie. 34(7). 392–394. 4 indexed citations
19.
Labouta, Ibrahim M., et al.. (1979). Potential Antineoplastics I: Substituted 3,5-Dioxo- and 3-Thioxo-5-oxo-2,3,4,5-tetrahydro-1,2,4-triazines. Journal of Pharmaceutical Sciences. 68(2). 243–245. 5 indexed citations
20.
Labouta, Ibrahim M., et al.. (1978). Synthesis of 5,6-Diaryl-1,2,4-triazines. Zeitschrift für Naturforschung B. 33(12). 1503–1507. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026